Outstanding performance

Hollings has received the renewal of its five-year National Cancer Institute Cancer Center Support Grant, earning its best score ever in the process.

Read about the renewal
a woman looks into a microscope in a research lab while a man and a woman look on behind her

News

Facebook icon Twitter icon Instagram icon LinkedIn logo icon

 

Clinical trial of purified CAR-T cell therapy awarded $3.2M NCI grant to expand

a man in jeans and loose black leather jacket leans forward, smiling broadly, while sitting on an exam chair in an exam room

With the first two patients in a clinical trial testing purified CAR-T cells both showing complete remission, the National Cancer Institute has stepped forward with $3.2 million in funding to expand the trial.

“To be the first person to have the purified cells – like I mentioned to Doctor Hess, ‘First time up and you guys hit one out of the park,’” said trial participant Ted Kopacko.

Read about the trial

What’s great is now everyone can get it. Anyone can prescribe it. They don’t have to travel somewhere to get this medication. It really is a huge help for our families and kids.

Dr. Jacqueline Kraveka, pediatric cancer researcher

Read about the new drug
Jacqueline Kraveka headshot

 

Featured video

An ovarian cancer diagnosis was the last thing that Carol Sullivan expected. But with support from friends and family and her care team at MUSC Hollings Cancer Center, she's successfully come through treatment. Watch her inspiring story below.

Explore the News Center

Hollings Horizons Magazine   |   Media Relations   |   Cross Talk   |   Subscribe